From the tokenization of real-world assets to funding research on anti-aging therapeutics, Coinbase co-founder and CEO Brian Armstrong is focused on solving meta-problems for the benefit of society. Brian joins Elad Gil this episode to discuss the intersections of artificial intelligence, crypto rails, and biotechnology. He details Coinbase’s vision for agentic finance, as well as how Coinbase is becoming the ‘Everything Exchange’, which includes tokenized real-world stocks, stablecoin payment adoption, and prediction markets. Brian also introduces his new venture, New Limit, a company founded to tackle longevity through epigenetic reprogramming, and outlines initial therapeutic programs and the roadmap toward clinical trials.
Sign up for new podcasts every week. Email feedback to
[email protected]
Follow us on Twitter: @NoPriorsPod | @Saranormous | @EladGil | @brian_armstrong | @Coinbase
Chapters:
00:00 – Cold Open Trailer
00:45 – Brian Armstrong Introduction
01:13 – Coinbase and the Everything Exchange
05:52 – Agentic Commerce
10:00 – AI and Crypto
10:49 – AI Inside Coinbase
15:39 – Productivity and Company Size
17:26 – The Everything Exchange and Tokenization
20:53 – Prediction Markets
23:15 – Introducing New Limit
34:17 – Looking Forward Five Years
40:24 – Special Economic Zones
44:26 – Conclusion
